 |
 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
Patients should discuss the advantages and disadvantages of the various colorectal cancer screening tests with their doctors to decide which test is best for them. The frequency of screening depends on the test a patient uses: every 1 to 2 years for FOBT, every 5 years for sigmoidoscopy and barium enema, and every 10 years for colonoscopy.
SUMMARIES FOR PATIENTS
Screening for Colorectal Cancer: Recommendations from the United States Preventive Services Task Force
16 July 2002 | Volume 137 Issue 2 | Page I-38
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.
The summary below is from the full reports titled "Cost-Effectiveness Analyses of Colorectal Cancer Screening: A Systematic Review for the U.S. Preventive Services Task Force," "Screening for Colorectal Cancer: Recommendation and Rationale," and "Screening for Colorectal Cancer in Adults at Average Risk: A Summary of the Evidence for the U.S. Preventive Services Task Force." They are in the 16 July 2002 issue of Annals of Internal Medicine (volume 137, pages 96-104, 129-131, and 132-141). The first report was written by M Pignone, S Saha, T Hoerger, and J Mandelblatt; the second report was written by the U.S. Preventive Services Task Force; and the third report was written by M Pignone, M Rich, SM Teutsch, AO Berg, and KN Lohr.
What is the United States Preventive Services Task Force?
The United States Preventive Services Task Force (USPSTF) is a group of physicians and health care experts that reviews published research and makes recommendations about preventive health care.
What is the problem and what is known about it so far?
Colorectal cancer is one of the most common types of cancer. Screening prevents colorectal cancer deaths by 1) finding and removing noncancerous outgrowths of the colon or rectum [polyps] before they become cancer and 2) finding cancer at early, curable stages. Available screening tests include fecal occult blood testing (FOBT), sigmoidoscopy, colonoscopy, and barium enema. Fecal occult blood testing uses a chemical reaction to find traces of blood in stool. Polyps and cancer can cause blood to leak into the stool, so a positive result on FOBT suggests the need for further testing. Sigmoidoscopy involves looking into the rectum and lower colon through a flexible tube-shaped instrument; colonoscopy uses a similar but longer instrument to look at the entire length of the colon. Doctors can take samples of the colon (biopsies) and remove polyps during both procedures. Barium enema involves taking x-rays of the abdomen after putting barium (a material that appears white on x-ray) into a person's colon by enema. If x-rays indicate a lesion in the colon, follow-up testing with colonoscopy is needed. Fecal occult blood testing is inexpensive, colonoscopy is expensive, and sigmoidoscopy and barium enema are moderately priced.
How did the USPSTF develop these recommendations?
The USPSTF reviewed published research to evaluate the benefits, harms, and costs of screening for colorectal cancer.
What did the authors find?
Several high-quality studies show that FOBT helps to decrease colorectal cancer deaths by up to one third among adults over age 50. Studies showing the effectiveness of sigmoidoscopy and colonoscopy are of lower quality but also show benefits. Barium enema can also detect polyps and cancer, but the effect of barium enema on deaths from colorectal cancer is unknown. Existing studies are unable to tell us which test is best. The seven studies of the cost-effectiveness of colorectal cancer screening found all tests to be cost-effective but could not identify a single best strategy or determine the best age to start and stop screening.
What does the USPSTF suggest that patients do?
The USPSTF strongly recommends that adults begin screening for colorectal cancer at age 50, the age at which risk starts to increase in the general population. The best options for screening include FOBT, sigmoidoscopy (alone or with FOBT), or colonoscopy. Barium enema is also an option, but it is less accurate than colonoscopy and its effects on colorectal cancer deaths are unknown. The Task Force did not recommend a specific screening test.
What are the cautions related to these recommendations?
These recommendations do not apply to people who have a family history or a personal history that puts them at high risk for colorectal cancer. As better studies become available, the USPSTF may modify these recommendations.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  U.S. Preventive Services Task Force Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med, November 4, 2008; 149(9): 627 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Whitlock, J. S. Lin, E. Liles, T. L. Beil, and R. Fu Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force Ann Intern Med, November 4, 2008; 149(9): 638 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pignone and H. C. Sox Screening Guidelines for Colorectal Cancer: A Twice-Told Tale Ann Intern Med, November 4, 2008; 149(9): 680 - 682. [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Pickhardt, C. Hassan, A. Laghi, A. Zullo, D. H. Kim, F. Iafrate, and S. Morini Clinical Management of Small (6- to 9-mm) Polyps Detected at Screening CT Colonography: A Cost-Effectiveness Analysis Am. J. Roentgenol., November 1, 2008; 191(5): 1509 - 1516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Chung Stool DNA Testing and Colon Cancer Prevention: Another Step Forward Ann Intern Med, October 7, 2008; 149(7): 509 - 510. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Levin, D. A. Lieberman, B. McFarland, R. A. Smith, D. Brooks, K. S. Andrews, C. Dash, F. M. Giardiello, S. Glick, T. R. Levin, et al. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology CA Cancer J Clin, May 1, 2008; 58(3): 130 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Schneider, M. R. Nadel, A. M. Zaslavsky, and E. A. McGlynn Assessment of the Scientific Soundness of Clinical Performance Measures: A Field Test of the National Committee for Quality Assurance's Colorectal Cancer Screening Measure Arch Intern Med, April 28, 2008; 168(8): 876 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Jonas, L. B. Russell, R. S. Sandler, J. Chou, and M. Pignone Value of Patient Time Invested in the Colonoscopy Screening Process: Time Requirements for Colonoscopy Study Med Decis Making, February 1, 2008; 28(1): 56 - 65. [Abstract] [PDF]
|
|
|
|
|
|
P. J. Pickhardt, C. Hassan, A. Laghi, A. Zullo, D. H. Kim, F. Iafrate, and S. Morini Small and Diminutive Polyps Detected at Screening CT Colonography: A Decision Analysis for Referral to Colonoscopy Am. J. Roentgenol., January 1, 2008; 190(1): 136 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Braithwaite, J. Concato, C. C. Chang, M. S. Roberts, and A. C. Justice A Framework for Tailoring Clinical Guidelines to Comorbidity at the Point of Care Arch Intern Med, November 26, 2007; 167(21): 2361 - 2365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Brenner, M. Hoffmeister, C. Stegmaier, G. Brenner, L. Altenhofen, and U. Haug Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies Gut, November 1, 2007; 56(11): 1585 - 1589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B Ballinger and C. Anggiansah Colorectal cancer BMJ, October 6, 2007; 335(7622): 715 - 718. [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Allison, L. C. Sakoda, T. R. Levin, J. P. Tucker, I. S. Tekawa, T. Cuff, M. P. Pauly, L. Shlager, A. M. Palitz, W. K. Zhao, et al. Screening for Colorectal Neoplasms With New Fecal Occult Blood Tests: Update on Performance Characteristics J Natl Cancer Inst, October 3, 2007; 99(19): 1462 - 1470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. F Ransohoff What is the role of iFOBT in screening for colorectal cancer? Gut, October 1, 2007; 56(10): 1343 - 1344. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Brenner, J. Chang-Claude, C. M. Seiler, T. Sturmer, and M. Hoffmeister Potential for Colorectal Cancer Prevention of Sigmoidoscopy Versus Colonoscopy: Population-Based Case Control Study Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 494 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J G Williams, S E Roberts, M F Ali, W Y Cheung, D R Cohen, G Demery, A Edwards, M Greer, M D Hellier, H A Hutchings, et al. Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence Gut, February 1, 2007; 56(suppl_1): 1 - 113. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Losina, R. P. Walensky, A. Geller, F. C. Beddingfield III, L. L. Wolf, B. A. Gilchrest, and K. A. Freedberg Visual Screening for Malignant Melanoma: A Cost-effectiveness Analysis Arch Dermatol, January 1, 2007; 143(1): 21 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Brenner, J Chang-Claude, C M Seiler, T Sturmer, and M Hoffmeister Does a negative screening colonoscopy ever need to be repeated? Gut, August 1, 2006; 55(8): 1145 - 1150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Black Randomized Clinical Trials for Cancer Screening: Rationale and Design Considerations for Imaging Tests J. Clin. Oncol., July 10, 2006; 24(20): 3252 - 3260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Taylor A 71-Year-Old Woman Contemplating a Screening Colonoscopy JAMA, March 8, 2006; 295(10): 1161 - 1167. [Full Text] [PDF]
|
|
|
|
|
|
M. S. Wolf, K. A. Fitzner, E. F. Powell, K. R. McCaffrey, A. S. Pickard, J. M. McKoy, J. Lindenberg, G. T. Schumock, K. R. Carson, M. R. Ferreira, et al. Costs and Cost Effectiveness of a Health Care Provider-Directed Intervention to Promote Colorectal Cancer Screening Among Veterans J. Clin. Oncol., December 1, 2005; 23(34): 8877 - 8883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Coco The Cost-Effectiveness of Expanded Testing for Primary HIV Infection Ann. Fam. Med, September 1, 2005; 3(5): 391 - 399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pignone, S. Saha, T. Hoerger, K. N. Lohr, S. Teutsch, and J. Mandelblatt Challenges in Systematic Reviews of Economic Analyses Ann Intern Med, June 21, 2005; 142(12_Part_2): 1073 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Lee, C. LeBaron, T. V. Murphy, S. Lett, S. Schauer, and T. A. Lieu Pertussis in Adolescents and Adults: Should We Vaccinate? Pediatrics, June 1, 2005; 115(6): 1675 - 1684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Wackerbarth, J. C. Peters, and S. A. Haist "Do We Really Need All That Equipment?": Factors Influencing Colorectal Cancer Screening Decisions Qual Health Res, April 1, 2005; 15(4): 539 - 554. [Abstract] [PDF]
|
|
|
|
|
|
S. Subramanian, M. M. Amonkar, and T. L. Hunt Use of Colonoscopy for Colorectal Cancer Screening: Evidence from the 2000 National Health Interview Survey Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 409 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Haug and H. Brenner A Simulation Model for Colorectal Cancer Screening: Potential of Stool Tests with Various Performance Characteristics Compared with Screening Colonoscopy Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 422 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Rozen, M. Pignone, M. Crespi, D. Criblez, S. A. El-Badawy, R. Leicester, S. Otto, C. Pox, M. Richards, D. Smith, et al. Workgroup V: professional education and advocacy. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002) Ann. Onc., January 1, 2005; 16(1): 42 - 45. [Full Text] [PDF]
|
|
|
|
|
|
R. A. Smith, V. Cokkinides, and H. J. Eyre American Cancer Society Guidelines for the Early Detection of Cancer, 2005 CA Cancer J Clin, January 1, 2005; 55(1): 31 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. F. Imperiale, D. F. Ransohoff, S. H. Itzkowitz, B. A. Turnbull, M. E. Ross, and the Colorectal Cancer Study Group Fecal DNA versus Fecal Occult Blood for Colorectal-Cancer Screening in an Average-Risk Population N. Engl. J. Med., December 23, 2004; 351(26): 2704 - 2714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Woolf A Smarter Strategy? -- Reflections on Fecal DNA Screening for Colorectal Cancer N. Engl. J. Med., December 23, 2004; 351(26): 2755 - 2758. [Full Text] [PDF]
|
|
|
|
|
|
J. E. Lafata, J. Simpkins, L. Lamerato, L. Poisson, G. Divine, and C. C. Johnson The Economic Impact of False-Positive Cancer Screens Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2126 - 2132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Zapka, S. C. Lemon, E. Puleo, B. Estabrook, R. Luckmann, and S. Erban Patient Education for Colon Cancer Screening: A Randomized Trial of a Video Mailed before a Physical Examination Ann Intern Med, November 2, 2004; 141(9): 683 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Battat, R. V. Rouse, L. Dempsey, B. Y. Safadi, and S. M. Wren Institutional Commitment to Rectal Cancer Screening Results in Earlier-Stage Cancers on Diagnosis Ann. Surg. Oncol., November 1, 2004; 11(11): 970 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Fryback and B. M. Craig Measuring Economic Outcomes of Cancer J Natl Cancer Inst Monographs, October 1, 2004; 2004(33): 134 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Singh, L. F. Paszat, C. Li, J. He, C. Vinden, and L. Rabeneck Association of socioeconomic status and receipt of colorectal cancer investigations: a population-based retrospective cohort study Can. Med. Assoc. J., August 31, 2004; 171(5): 461 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. F. Ransohoff Virtual Colonoscopy--What It Can Do vs What It Will Do JAMA, April 14, 2004; 291(14): 1772 - 1774. [Full Text] [PDF]
|
|
|
|
|
|
S. H. Taplin, L. Ichikawa, D. S. M. Buist, D. Seger, and E. White Evaluating Organized Breast Cancer Screening Implementation: The Prevention of Late-Stage Disease? Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 225 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sosna, M. M. Morrin, J. B. Kruskal, P. T. Lavin, M. P. Rosen, and V. Raptopoulos CT Colonography of Colorectal Polyps: A Metaanalysis Am. J. Roentgenol., December 1, 2003; 181(6): 1593 - 1598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Sabichi, M.-F. Demierre, E. T. Hawk, C. E. Lerman, and S. M. Lippman Frontiers in Cancer Prevention Research Cancer Res., September 15, 2003; 63(18): 5649 - 5655. [Full Text] [PDF]
|
|
|
|
|
|
R. H. Fletcher Screening Sigmoidoscopy-- How Often and How Good? JAMA, July 2, 2003; 290(1): 106 - 108. [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Colucci, S. H. Yale, and C. J. Rall Colorectal Polyps Clin. Med. Res., July 1, 2003; 1(3): 261 - 262. [Full Text] [PDF]
|
|
|
|
|
|
B. Budenholzer Screening for Colorectal Cancer Ann Intern Med, February 18, 2003; 138(4): 356 - 356. [Full Text] [PDF]
|
|
|
|
|
|
R. S. Rosson and H. M. Spiro Screening for Colorectal Cancer Ann Intern Med, February 18, 2003; 138(4): 356 - 357. [Full Text] [PDF]
|
|
|
|
 |
|
 OTHER ARTICLES NOTED (Nov 01 to 18 Oct 02) Evid. Based Nurs., January 1, 2003; 6(1): e1 - 1. [Full Text] [PDF]
|
|
|
|
 |
|
 Screening for Colorectal Cancer Journal Watch Gastroenterology, September 11, 2002; 2002(911): 1 - 1. [Full Text]
|
|
|
|
 |
|
 Screening for Colorectal Cancer Journal Watch (General), August 13, 2002; 2002(813): 1 - 1. [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
